The making of a multinational, adaptive European COVID-19 trial network
The emergence of the COVID-19 pandemic has demonstrated the necessity of improving the global clinical trial capacity based on the cooperation between the EU and international partners. DisCoVeRy (WP1), designed as a multi-arm adaptive repurposing trial, can be expanded to several European countries with adequate multinational financing and trial management capacity. The EU-funded EU-RESPONSE project will establish a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, taking advantage of the existing initiatives, allowing the European expansion of DisCoVeRy (WP1) and the creation of a COVID-19 adaptive platform trial (WP2). The project will produce solid evidence for drug repurposing or registration, permitting most European hospitals to participate at their preferred level of commitment in establishing a network of investigation sites within the EU and associated countries.
Call for proposal
See other projects for this call
Funding SchemeRIA - Research and Innovation action
4200 319 Porto